Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma

Oral Oncology

Volumn 49, Issue 3, 2013, Pages 277-282

  Golden, D W ^a   Rudra, S ^a   Witt, M E ^a   Nwizu, T ^a   Cohen, E E W ^a   Blair, E ^a   Stenson, K M ^a   Vokes, E E ^a   Haraf, D J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Chemoradiotherapy; Head and neck neoplasms; Induction chemotherapy; Nasopharyngeal cancer; Pediatrics; Radiotherapy

Indexed keywords

FLUOROURACIL; HYDROXYUREA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHILD; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INDUCTION CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYDROXYUREA; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PLATINUM; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873414181     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.10.003     Document Type: Article

References (24)

1. M. Al-Sarraf, M. LeBlanc, P.G. Giri, K.K. Fu, J. Cooper, and T. Vuong Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310 1317
2. J. Wee, E.H. Tan, B.C. Tai, H.B. Wong, S.S. Leong, and T. Tan Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety J Clin Oncol 23 2005 6730 6738
3. B. Baujat, H. Audry, J. Bourhis, A.T. Chan, H. Onat, and D.T. Chua Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 64 2006 47 56
4. J.A. Langendijk, C.R. Leemans, J. Buter, J. Berkhof, and B.J. Slotman The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature J Clin Oncol 22 2004 4604 4612
5. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or =N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA I trial. Int J Radiat Oncol Biol Phys 1996; 35: 463-9.
6. D.T. Chua, J. Ma, J.S. Sham, H.Q. Mai, D.T. Choy, and M.H. Hong Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials J Clin Oncol 23 2005 1118 1124
7. D.T. Chua, J.S. Sham, D. Choy, V. Lorvidhaya, Y. Sumitsawan, and S. Thongprasert Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group Cancer 83 1998 2270 2283
8. J. Ma, H.Q. Mai, M.H. Hong, H.Q. Min, Z.D. Mao, and N.J. Cui Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 2001 1350 1357
9. A. Al-Amro, N. Al-Rajhi, Y. Khafaga, M. Memon, A. Al-Hebshi, and A. El-Enbabi Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 62 2005 508 513
10. A.T. Chan, B.B. Ma, Y.M. Lo, S.F. Leung, W.H. Kwan, and E.P. Hui Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA J Clin Oncol 22 2004 3053 3060
11. A.W. Lee, K.Y. Lau, W.M. Hung, W.T. Ng, M.C. Lee, and C.W. Choi Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma Radiother Oncol 87 2008 204 210
12. J.L. Oh, E.E. Vokes, M.S. Kies, B.B. Mittal, M.E. Witt, and R.R. Weichselbaum Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer Ann Oncol 14 2003 564 569
13. D. Rischin, J. Corry, J. Smith, J. Stewart, P. Hughes, and L. Peters Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation J Clin Oncol 20 2002 1845 1852
14. T.K. Yau, A.W. Lee, D.H. Wong, R.M. Yeung, E.W. Chan, and W.T. Ng Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma Head Neck 28 2006 880 887
15. P.W. Shueng, B.J. Shen, L.J. Wu, L.J. Liao, C.H. Hsiao, and Y.C. Lin Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma Radiat Oncol 6 2011 95
16. M. Airoldi, P. Gabriele, A.M. Gabriele, M. Garzaro, L. Raimondo, and F. Pedani Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma Cancer Chemother Pharmacol 67 2011 1027 1034
17. G. Fountzilas, E. Ciuleanu, M. Bobos, A. Kalogera-Fountzila, A.G. Eleftheraki, and G. Karayannopoulou Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation Ann Oncol 23 2012 427 435
18. E.P. Hui, B.B. Ma, S.F. Leung, A.D. King, F. Mo, and M.K. Kam Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma J Clin Oncol 27 2009 242 249
19. J.K. Salama, K.M. Stenson, E.O. Kistner, B.B. Mittal, A. Argiris, and M.E. Witt Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels Ann Oncol 19 2008 1787 1794
20. L.N. Zhao, B. Zhou, M. Shi, J.H. Wang, F. Xiao, and M. Xu Clinical outcome for nasopharyngeal carcinoma with predominantly WHO II histology treated with intensity-modulated radiation therapy in non-endemic region of China Oral Oncol 48 2012 864 869
21. F. Bray, M. Haugen, T.A. Moger, S. Tretli, O.O. Aalen, and T. Grotmol Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications Cancer Epidemiol Biomarkers Prev 17 2008 2356 2365
22. M. Deutsch, R. Mercado Jr., and J.A. Parsons Cancer of the nasopharynx in children Cancer 41 1978 1128 1133
23. I. Ayan, and M. Altun Nasopharyngeal carcinoma in children: retrospective review of 50 patients Int J Radiat Oncol Biol Phys 35 1996 485 492
24. K.J. Marcus, and R.B. Tishler Head and neck carcinomas across the age spectrum: epidemiology, therapy, and late effects Semin Radiat Oncol 20 2010 52 57